DarioHealth Corp
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 82.7% | 65.8% | 57.8% | 36.2% | 29.7% | 27.8% | 42.5% | 36.7% | 39.8% | 54.7% | 42.7% | 38.3% | 43.9% | |
| 17.3% | 34.2% | 42.2% | 63.8% | 70.3% | 72.2% | 57.5% | 63.3% | 60.2% | 45.3% | 57.3% | 61.7% | 56.1% | |
| 161.0% | 116.0% | 115.4% | 108.9% | 73.4% | 69.5% | 60.8% | 69.3% | 66.5% | 50.4% | 42.7% | 40.6% | 49.7% | |
| 117.3% | 149.4% | 117.0% | 80.0% | 50.2% | 56.4% | 49.0% | 59.8% | 91.2% | 78.4% | 57.8% | 50.2% | 69.0% | |
| -424.6% | -358.9% | -267.9% | -195.1% | -91.7% | -81.2% | -81.9% | -108.1% | 249.6% | 920.5% | 188.2% | 186.8% | 384.9% | |
| 441.9% | 393.1% | 310.1% | 258.8% | 162.1% | 153.4% | 139.4% | 171.4% | -189.4% | -875.2% | -130.9% | -125.1% | -328.8% | |
| 0.7% | 15.4% | 0.3% | 0.5% | 0.4% | 0.3% | 0.5% | 0.6% | 23.7% | 40.3% | 21.0% | 21.7% | 26.6% | |
| -447.2% | -393.3% | -159.2% | -217.6% | -166.3% | -124.6% | -136.3% | -241.9% | -209.0% | 1,804.5% | -146.7% | -146.7% | 324.5% | |
| -35.1% | 1.8% | -34.6% | -163.7% | -0.2% | 2.0% | 0.3% | – | – | -0.4% | 1.0% | 6.3% | – | |
| -447.2% | -395.0% | -124.6% | -217.6% | -166.1% | -126.7% | -136.7% | -241.9% | -41.5% | 1,644.6% | -147.7% | -153.1% | 322.8% | |
| -406.8% | -353.1% | -287.1% | -229.5% | -139.1% | -110.2% | -120.7% | -156.4% | -174.4% | -163.2% | -116.7% | -115.1% | -141.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.